Business · 29/09/1995Updated: 10/18/2026 · 1 min read
Colgate-Palmolive Co., et al.; FDA Withdraws Approval of 23 New Drug Applications
Summary
The US Food and Drug Administration (FDA) has withdrawn the approval of 23 new drug applications (NDAs) following notification from the applications' holders that the corresponding drug products are no longer commercially available.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →